Dan Ives, Wedbush global head of technology research, joins 'Closing Bell: Overtime' to discuss Salesforce after the ...
We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
Vivek Ramaswamy, the incoming co-chair of President-elect Donald Trump’s commission to cut government spending, has set his ...
There’s a 2% chance bitcoin can become all of money, which would then value the cryptocurrency at $5 million, analyst says ...
Wedbush analyst Daniel Ives says that in “another Twilight Zone” legal move from Chancellor McCormick of the Delaware Court of Chancery yet ...
Salesforce (CRM) is set to report fiscal third-quarter results tomorrow after the close of trading, and Wedbush Securities is ...
Fintel reports that on December 3, 2024, Wedbush downgraded their outlook for Cavco Industries (NasdaqGS:CVCO) from ...
Investing.com -- Wedbush analysts expect tech stocks to end the year strongly with a “Santa rally,” citing positive catalysts ...
In a report released today, Daniel Ives from Wedbush maintained a Buy rating on Salesforce (CRM – Research Report), with a price target of ...
Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...
Additionally, one closely watched Wall Street analyst said that AI software stocks would be winners in 2025. As a result, ...
Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...